Compare MYSZ & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYSZ | GCTK |
|---|---|---|
| Founded | 1999 | 2001 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5M | 3.0M |
| IPO Year | 2017 | 2011 |
| Metric | MYSZ | GCTK |
|---|---|---|
| Price | $0.44 | $0.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 94.5K | ★ 602.9K |
| Earning Date | 04-15-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.40 | N/A |
| EPS | N/A | ★ 2.65 |
| Revenue | $142,000.00 | ★ $589,462.00 |
| Revenue This Year | $41.64 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.14 |
| Revenue Growth | ★ 125.40 | N/A |
| 52 Week Low | $0.38 | $0.29 |
| 52 Week High | $1.65 | $15.90 |
| Indicator | MYSZ | GCTK |
|---|---|---|
| Relative Strength Index (RSI) | 38.65 | 32.77 |
| Support Level | N/A | $0.29 |
| Resistance Level | $0.67 | $1.02 |
| Average True Range (ATR) | 0.06 | 0.07 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 19.10 | 25.09 |
My Size Inc is a fashion technology company operating an integrated portfolio of businesses designed to address the pressing challenges facing fashion brands and retailers today - size and fit accuracy, excess inventory management, circular economy solutions, and international market distribution. The company, through its subsidaries provide end-to-end support across the fashion value chain; delivers AI-driven size and fit solutions for fashion e-commerce companies. The firm has the following four segments: (i) Fashion e-commerce platform, (ii) SaaS solutions, (iii) resale platform for apparel, and (iv) wholesaling of footwear. The company generates the majority of its revenue from the fashion e-commerce platform segment.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.